New York State Common Retirement Fund Portfolio holdings
AUM
$75.2B
1-Year Return
24.38%
This Quarter Return
+7.15%
1 Year Return
+24.38%
3 Year Return
+108.85%
5 Year Return
+192%
10 Year Return
+482.31%
AUM
$73.9B
AUM Growth
-$2.32B
(-3%)
Cap. Flow
-$6.62B
Cap. Flow
% of AUM
-8.95%
Top 10 Holdings %
Top 10 Hldgs %
29.96%
Holding
3,439
New
40
Increased
393
Reduced
2,144
Closed
261
Top Buys
| 1 |
CNA Financial
CNA
|
+$53.9M |
| 2 |
Trip.com Group
TCOM
|
+$41.4M |
| 3 |
SW
Smurfit Westrock plc
SW
|
+$22.3M |
| 4 |
BioNTech
BNTX
|
+$21.3M |
| 5 |
WEX
WEX
|
+$20.5M |
Top Sells
| 1 |
NVIDIA
NVDA
|
+$376M |
| 2 |
Apple
AAPL
|
+$359M |
| 3 |
Microsoft
MSFT
|
+$278M |
| 4 |
Amazon
AMZN
|
+$147M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$112M |
Sector Composition
| 1 | Technology | 31.52% |
| 2 | Financials | 12.89% |
| 3 | Healthcare | 12.35% |
| 4 | Consumer Discretionary | 10.61% |
| 5 | Industrials | 9.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3001
Olaplex Holdings
OLPX
$967M
| $18K | ﹤0.01% |
7,508
-90,342
| -92% | -$217K |
|
|
TRVG
3002
trivago
TRVG
$228M
| $18K | ﹤0.01% |
10,322
| – | – |
|
3003
Akebia Therapeutics
AKBA
$795M
| $17K | ﹤0.01% |
12,500
-88,600
| -88% | -$120K |
|
3004
Aemetis
AMTX
$141M
| $17K | ﹤0.01% |
7,200
-26,000
| -78% | -$61.4K |
|
|
BLUE
3005
DELISTED
bluebird bio
BLUE
| $17K | ﹤0.01% |
1,675
| – | – |
|
3006
Foghorn Therapeutics
FHTX
$307M
| $17K | ﹤0.01% |
1,871
| – | – |
|
3007
HilleVax
HLVX
$105M
| $17K | ﹤0.01% |
9,799
| – | – |
|
3008
Medallion Financial
MFIN
$249M
| $17K | ﹤0.01% |
2,100
-12,100
| -85% | -$98K |
|
3009
MacroGenics
MGNX
$109M
| $17K | ﹤0.01% |
5,244
-18,200
| -78% | -$59K |
|
3010
Organogenesis Holdings
ORGO
$620M
| $17K | ﹤0.01% |
5,792
| – | – |
|
3011
Provident Bancorp
PVBC
$227M
| $17K | ﹤0.01% |
1,600
-8,400
| -84% | -$89.3K |
|
3012
Rimini Street
RMNI
$426M
| $17K | ﹤0.01% |
9,177
| – | – |
|
3013
Rackspace Technology
RXT
$337M
| $17K | ﹤0.01% |
7,050
| – | – |
|
3014
Acrivon Therapeutics
ACRV
$51.9M
| $16K | ﹤0.01% |
2,314
| – | – |
|
3015
Arteris
AIP
$372M
| $16K | ﹤0.01% |
2,100
-11,600
| -85% | -$88.4K |
|
3016
Energy Vault
NRGV
$286M
| $16K | ﹤0.01% |
16,835
| – | – |
|
3017
Stereotaxis
STXS
$263M
| $16K | ﹤0.01% |
7,600
-49,300
| -87% | -$104K |
|
3018
Verastem
VSTM
$611M
| $16K | ﹤0.01% |
5,200
-29,300
| -85% | -$90.2K |
|
3019
Concrete Pumping Holdings
BBCP
$360M
| $15K | ﹤0.01% |
2,531
-447,172
| -99% | -$2.65M |
|
3020
BRC Inc
BRCC
$180M
| $15K | ﹤0.01% |
4,345
-81,668
| -95% | -$282K |
|
3021
Editas Medicine
EDIT
$248M
| $15K | ﹤0.01% |
4,394
-24,400
| -85% | -$83.3K |
|
3022
Mama's Creations
MAMA
$355M
| $15K | ﹤0.01% |
2,100
-12,500
| -86% | -$89.3K |
|
3023
Rekor Systems
REKR
$153M
| $15K | ﹤0.01% |
12,300
-51,900
| -81% | -$63.3K |
|
3024
Target Hospitality
TH
$869M
| $15K | ﹤0.01% |
1,964
-63,100
| -97% | -$482K |
|
3025
Solarmax Technology
SMXT
$59.2M
| $15K | ﹤0.01% |
23,600
| – | – |
|